GenProbe (GPRO) up 8%+on Buy-Out Rumors

Speculation chat is driving up shares of GenProbe (GPRO) on heavier volume of 2.5M shares. Two stories are notable one from the Wall Street Journal on ThermoFisher (TMO) a potential bidder, but also interested in Phadia AB an allergy testing Co., and the other on a collaboration between GenProbe (GPRO) and  Life Technologies(LIFE).

On the short list of buyers is JNJ,Life Technologies and current partner Novartis (NVS).

No comments yet.

Leave a Reply